OLGRAM
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.Olgram has an original positioning to address this critical need by developing new products that will target, for the first time, dormant bacteria (responsible for infectious relapses) with a new class of anti-infectious.
OLGRAM
Industry:
Biotechnology Medical
Founded:
2019-01-01
Address:
Bréhan-loudéac, Bretagne, France
Country:
France
Website Url:
http://www.olgram.com
Total Employee:
1+
Status:
Active
Contact:
+33 (0)6 75 69 31 30
Email Addresses:
[email protected]
Total Funding:
1.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Universal Analytics Mobile Optimized Drupal
Similar Organizations
Torus Biosystems
Torus Biosystems is a biotech startup that delivers molecular diagnostics for infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Seed Round - Olgram
Official Site Inspections
http://www.olgram.com Semrush global rank: 5.46 M Semrush visits lastest month: 1.56 K
- Host name: cluster023.hosting.ovh.net
- IP address: 164.132.235.17
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Olgram"
Olgram - Innovations from the sea to tackle infectious …
Olgram relies upon its international and complementary team of experts involved in research, drug development, pharmaceutical and industrial sucesses to develop the next immunotherapies. Learn more Jobs . Join an international …See details»
Team - Olgram
Maryvonne created Olgram in 2019. She has built the company strategy, management team and executed the development plan since then. Before that Maryvonne led during 14 years a nuclear program at FRAMATOME (Areva). …See details»
Olgram - Crunchbase Company Profile & Funding
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.Olgram has an original positioning to address this critical …See details»
Olgram SA – Swiss Biotech
The passion, determination and expertise of Olgram’s management and founders have led to many important developments in the field of medicine, driven by innovation and the …See details»
Our vision - Olgram
Programs . Our pipeline: Delivering first-in-class immunotherapies of activation and regulation. We develop 2 different classes of therapeutic molecules in our 2 areas of expertise within our …See details»
Olgram - LinkedIn
Olgram is a biotechnology company developing first-in-class, proprietary immunotherapies to treat immune deficiencies, beginning with immuno-depression after traumatic brain injury and …See details»
Olgram Company Profile 2024: Valuation, Funding & Investors
Nov 19, 2020 Olgram General Information Description. Operator of a biotechnology company intended to fight immune deficiency post-traumatic brain injury and concussions. The …See details»
Olgram - BioAlps
Olgram is a biotechnology company developing 2 programs : – a first in class molecule with the unique property to cure immune diseases with original target and mechanism of action …See details»
Olgram SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Olgram SAS with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Infectious Diseases, Technology Platform:Unknown, Drug:NAIAP-OL20-01, MIAMI …See details»
Olgram Company Profile - Office Locations, Competitors, Revenue …
Olgram is a biotechnology company developing marine molecules and a proprietary screening platform to test and modify molecules. It develops NAIAP-OL20-01 and MIAMI-OL20-11 …See details»
Contact - Olgram
Email E. [email protected] . Switzerland . FONGIT Route de la Galaise, 34 1228 Plan-les-Ouates, Geneva Switzerland Phone T. +41 78 217 74 05 . Email E. [email protected] . …See details»
Olgram - Funding, Financials, Valuation & Investors - Crunchbase
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections. Search Crunchbase. ... How much funding has this …See details»
Olgram Raises €1.5M in Seed Funding - FinSMEs
Apr 5, 2021 Olgram, a Brehan, France-based biotechnology company developing marine molecules for the prevention and control of bacterial infections, raised €1.5m in seed funding. …See details»
Pierre Rocheteau - Founder and CEO @ Olgram - Crunchbase
Pierre Rocheteau joined Olgram as Founder and CEO in 2021 and he attended Pierre and Marie Curie University (Paris VI) in 2006. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Olgram Raises $1.77M for New Class of Antibiotics to Treat CF...
Apr 6, 2021 In a second phase, Olgram will target hospital-acquired infections in patients whose immune systems weaken (immunocompromised patients) after head trauma. “We are …See details»
History - Olgram
Olgram receive the support from the Britanny region via its Inno R&D collaborative. April 2021 . Olgram designed as Gold company by the European Investor Network. Dec 2022 . Winner of …See details»
Olgram - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Olgram | EU-Startups
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.Olgram has an original positioning to address this critical …See details»
MIAMI Program - Olgram
The World Health Organization (WHO) estimates that traumatic brain injury is the third leading cause of death and disability in 2019 and its economic impact in the United States and Europe …See details»
Job offers - Olgram
Olgram biotech company Olgram biotech company: Olgram is a biotechnology company, that fights against antibiotic persistence by developing 2 programs: i) the discovery and …See details»